Day: July 20, 2020

Duchesnay USA, Maker of Osphena®, Applauds Expanded Coverage for Treatments for Dyspareunia due to Menopause under Medicare Part D

ROSEMONT, PA, /PRNewswire/ – Duchesnay USA commends the clarification by the Centers for Medicare and Medicaid Services (CMS) of the statutory intent of “Prescription Drug Benefits” Section 1860D-2(e)(2)(A) of the Social Security Act. In its statement, the CMS confirmed that drugs indicated for the treatment of moderate to severe dyspareunia (painful intercourse) due to menopause are Read more…

Anxious and forgetful after menopause? Here’s why

(SCIENCE DAILY) – Lack of estrogen may play a role in the development of anxiety and memory problems, according to a new rodent study. The findings will be presented today at the American Physiological Society’s (APS) Cardiovascular, Renal and Metabolic Diseases: Sex-Specific Implications for Physiology conference in Knoxville, Tennesee. Estrogen, the primary female sex hormone, Read more…

subscribe to our newsletter

let's subscribe!

Newsletter